Ella Instrument- Automated Immunoassay Machine acquisition

The National Institutes of Health (NIH), specifically the National Institute of Neurological Disorders and Stroke (NINDS), has issued a presolicitation notice for the acquisition of an Ella Automated Immunoassay Machine. The Translational Neuroradiology Section requires this technology to study the mechanisms of multiple sclerosis and related neuroinflammatory pathologies within the central nervous system. The Ella Immunoassay System, manufactured by Bio-Techne, provides multiplexed protein analysis for serum and plasma samples, enabling the quantification of biomarkers like neurofilament light chain and glial fibrillary acidic protein. This high-throughput, high-sensitivity platform is essential for maintaining the analytical precision and reproducibility required for the section’s ongoing translational neuroimmunology investigations.

This requirement is identified under solicitation number 75N98026Q00510 and is classified under NAICS code 334516, Analytical Laboratory Instrument Manufacturing, and PSC code 6640, Laboratory Equipment and Supplies. There is no set-aside designated for this procurement. Performance will take place in Bethesda, Maryland, under the direction of the NIH Office of Logistics and Acquisition Operations.

Interested parties must submit responses by the deadline of June 8, 2026. Vishnuvajjala Hanumanth Rao is the designated point of contact for this notice, which includes one attachment titled index.pdf. The acquisition aims to support the rigor and reproducibility necessary for high-impact research into axonal damage and astrocyte activation.